Jefferies Maintains Buy on Bausch Health Companies, Raises Price Target to $9.5
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst David Steinberg maintains a Buy rating on Bausch Health Companies (NYSE:BHC) and raises the price target from $7 to $9.5.
May 22, 2023 | 12:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst David Steinberg maintains a Buy rating on Bausch Health Companies and raises the price target from $7 to $9.5.
The news of Jefferies maintaining a Buy rating and raising the price target for Bausch Health Companies (BHC) from $7 to $9.5 is positive for the stock. This indicates that the analyst has a positive outlook on the company's performance and believes that the stock is undervalued at its current price. This could lead to an increase in demand for the stock and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100